|Bid||32.900 x 500|
|Ask||32.910 x 1600|
|Day's Range||32.770 - 33.410|
|52 Week Range||27.600 - 56.440|
|PE Ratio (TTM)||422.50|
|Dividend & Yield||1.36 (4.17%)|
|1y Target Est||N/A|
Why are shares of Valeant Pharmaceuticals International (VRX) rising and does the market have it right? According to Evercore ISI analyst Umer Raffat, anytime the market receives a signal of some sort that the embattled drug maker has value beyond its pile of debt, the stock price rises and short sellers cover their positions. Today, a 7.8% spike in Valeant’s share price is linked to speculation that a debt-to-equity swap could be on the horizon, Raffat says.
We issued an updated research report on Allergan plc (AGN) on Jun 23.
To keep his anxiety under control, Peter, a 35-year-old government employee, relied for nine years on a blue-and-white pill he popped every night before bed: Cymbalta, made by Eli Lilly & Co. When a generic ...